CARDIOPROTECTIVE AND ANTI INFLAMMATORY EFFECTS OF A SELECTIVE INHIBITOR OF THE SODIUM GLUCOSE COTRANSPORTER 2 (EMPAGLIFOZIN) IN DOXORUBICIN INDUCED CARDIOTOXICITY
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)31266-5
Abstract: Empagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter 2 (SGLT2), reduced the risk of hospitalization for heart failure or cardiovascular death in type 2 diabetic patients. The mechanism by which EMPA induces cardiovascular… read more here.
Keywords: inhibitor sodium; selective inhibitor; cardioprotective anti; sodium glucose ... See more keywords